Open Orphan Share Discussion Threads

[pierre oreilly] 26/11/2020 11:03

Hvivo are doing phase 1 for the codagenics vaccine, nothing at all to do with a challenge study.C has always said the covid cha stu start in Jan. ATM the covid model is being developed, as has been ongoing for months, with orph getting 10m for work they'd already done. It's probably ready now, but the RF has planned in Jan for the cha stu start.Imo afaiia

[1gw] 26/11/2020 11:02

The codagenix trial is a Phase 1 trial of a vaccine which is based on an attenuated version of the virus. So that's different from a challenge study. They will be giving the vaccine to healthy volunteers to see what if any side effects there are - i.e. if it is safe. Having said that, because the vaccine is based on an attenuated version of the virus there may be some of the same concerns that exist around a challenge study - and that may also be why they want to do the study in a quarantine facility.

At least that's how I interpret it.

[m5] 26/11/2020 10:59

owenski26 Nov '20 - 10:39 - 8694 of 8698

Exactly.

This trading range we are currently in is getting tighter and tighter. It's a coiled spring IMHO, DYOR. Look up pennant, google images, and compare to what is happening here on our chart..

[gregb] 26/11/2020 10:52

Pogue, I'll ask him to confirm at the next investor presentation on the 9th.

[pogue] 26/11/2020 10:49

GregB
so we are off and running on CV19 trials, they earn more money than the normal ones so nice finish to the year, I thought HM Gov had the first 3 in Jan.

[gregb] 26/11/2020 10:44

Yes Pouge, he said December.OO had a mention in this article back in August.https://www.biospace.com/article/biotech-startup-codagenix-plans-human-trials-for-covid-19-vaccine/

[pierre oreilly] 26/11/2020 10:44

Oh he's funny. Funniest thing I've heard in a longtime.

Is that all proven cathal?

No, it's a guess.

Really, I think he should have catchpole answering pharma questions, and c answering the business questions.

[owenski] 26/11/2020 10:39

WRT the CEO,

A lot of companies in this space are populated by directors that have a PHD background and know their science, but businessmen they aint. CF is, the company is run by relevant science background staff, he's the business brain converting that know how into revenue.

[judijudi] 26/11/2020 10:34

m5,
He has a very impressive salesman’s patter, that’s for sure

[pogue] 26/11/2020 10:33

Codagenix phase 1 CV19 vaccine being tested by ORPH in December according to IG interview on above presentation, circa 4 mins in, we must have a challenge study model approved? Am I hearing that wrong?

[m5] 26/11/2020 10:29

Jut listened to that all the way through, as you say very interesting. CF is certainly positive about the future in general, not just ORPH, and see's a lot of opportunities. Very bright and switched on bloke CF. He does have the effect on you wanting to buy more shares everytime he talks. As someone that knew nothing about the Industry he certainly has come a bloody long way and sees all the opportunities that maybe others just don't see. Massive asset for us.

[realcooltrader] 26/11/2020 10:19

Yes, thanks toyin, very interesting.

[m5] 26/11/2020 10:01

Cheers toyin.

[uapatel] 26/11/2020 09:49

Hopefully that November update brings some clarity for some institutional investors on the money being generated.

[m5] 26/11/2020 09:46

I agree we have a steady buyer that does not want to push the price up. I wonder why they are buying now. Do we have some news due anytime? :-)

[malcolmmm] 26/11/2020 09:38

I agree that someone is quietly buying on a daily basis so as not to raise the price as the shares are very liquid at the moment

[judijudi] 26/11/2020 09:33

😂🤣👏👏

[toyin] 26/11/2020 09:31

Judi, it's "pin bars" not "behind bars”! 😉

[judijudi] 26/11/2020 09:29

😃😃

[extrader] 26/11/2020 09:27

Hi judujudi,

'Parkhurst' ? That's a bit unPC, surely (Shirley) ? What about 'Holloway' ;-> ?

ATB

[judijudi] 26/11/2020 09:14

Where
Parkhurst? 😃

[bramble13] 26/11/2020 09:09

We have break out.

[trader_3] 26/11/2020 08:52

Shares Spotlight Article – ORPH

hxxps://issuu.com/shares-magazine/docs/spotlight_shares_2611120

[warranty] 26/11/2020 08:23

Supernumerary, cruel ;-)